4.59
Myriad Genetics Inc (MYGN) 最新ニュース
Is Myriad Genetics Inc. a good long term investmentHigh-performance investment picks - jammulinksnews.com
Myriad Genetics Inc. Stock Analysis and ForecastExceptional profit velocity - jammulinksnews.com
What drives Myriad Genetics Inc. stock priceMarket-beating returns - jammulinksnews.com
What analysts say about Myriad Genetics Inc. stockTremendous growth potential - Autocar Professional
Insider Sellers Might Regret Selling Myriad Genetics Shares at a Lower Price Than Current Market Value - simplywall.st
Volatile Stocks to Avoid: Williams-Sonoma, Timken, and Myriad Genetics - AInvest
Evolent Health, West Pharmaceutical Services, Myriad Genetics, Tandem Diabetes, and Integra LifeSciences Shares Are Falling, What You Need To Know - Yahoo Finance
Trading (MYGN) With Integrated Risk Controls - news.stocktradersdaily.com
Myriad Genetics Earns 2025 Great Place To Work Certification™ - The Manila Times
Myriad Genetics Outperforms Average US Company by 30% in Workplace Excellence - Stock Titan
Acadia Healthcare, 10x Genomics, Amphastar Pharmaceuticals, Myriad Genetics, and QuidelOrtho Stocks Trade Down, What You Need To Know - MSN
Myriad Genetics (MYGN) Drops 3.85% Despite Expansion Efforts - AInvest
Parp Inhibitor Biomarkers Market Is Booming So Rapidly By 2032 | Myriad Genetics, Inc., F. Hoffmann-La Roche AG - openPR.com
Where are the Opportunities in (MYGN) - news.stocktradersdaily.com
5 Revealing Analyst Questions From Myriad Genetics’s Q1 Earnings Call - Yahoo Finance
INVESTOR ALERT: Investigation of Myriad Genetics, Inc. (MYGN) Announced by Holzer & Holzer, LLC - GlobeNewswire
Should You Hold Myriad Genetics Stock in Your Portfolio Right Now? - MSN
Myriad Genetics at Goldman Sachs Conference: Strategic Growth Amid Challenges - Investing.com Canada
Transcript : Myriad Genetics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 02 - MarketScreener
Consumer Genomics Market Is Booming So Rapidly 2025-2032 | Color - openPR.com
5-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline is Approaching - ACCESS Newswire
3 Reasons to Avoid MYGN and 1 Stock to Buy Instead - Yahoo Finance
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline is Approaching - ACCESS Newswire
Myriad (MYGN) Up 23.9% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Myriad Genetics Announces Early Access to the FirstGene Multiple Prenatal Screen - GlobeNewswire
7-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline is Approaching - ACCESS Newswire
FINAL DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Myriad Genetics (MYGN) Investors Who Suffered Significant Losses to Contact Its Attorneys, Application Deadline Tomorrow - ACCESS Newswire
Trend Tracker for (MYGN) - news.stocktradersdaily.com
US Direct-To-Consumer Genetic Testing Market Report 2025, - GlobeNewswire
US Direct-To-Consumer Genetic Testing Market Report 2025, Competitive Analysis of 23andMe, Gene by Gene, Ancestry, Genesis, EasyDNA, Veritas, Myriad Genetics, Taconic Biosciences, & Color Health - Yahoo Finance
Myriad Genetics (MYGN) Launches FirstGene Multiple Prenatal Screen | MYGN Stock News - GuruFocus
大文字化:
|
ボリューム (24 時間):